Treatment-related toxicities in patients with squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Yood, M. Ulcickas [1 ]
Wang, P. Feng [2 ]
Zhao, Z. [2 ]
Alford, S. Hensley [3 ]
Oliveria, S. [1 ]
Wells, K. [3 ]
Phillips, S. [1 ]
Ali, H. [4 ]
O'Malley, C. [2 ]
机构：
[1] EpiSource LLC, Hamden, CT USA
[2] Amgen Inc, Global Epidemiol, Thousand Oaks, CA USA
[3] Henry Ford Hlth Syst, Biostat & Res Epidemiol, Detroit, MI USA
[4] Henry Ford Med Grp, Detroit, MI USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71612-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [1] TREATMENT-RELATED TOXICITIES IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    Yood, M. U.
    Wang, F.
    Zhao, Z.
    Alford, S. H.
    Oliveria, S.
    Wells, K.
    Phillips, S.
    Ali, H.
    O'Malley, C.
    Barber, B.
    VALUE IN HEALTH, 2009, 12 (07) : A225 - A225
  • [2] Treatment- related toxicities in patients with squamous cell carcinoma of the head and neck (SCCHN)
    Yood, M. Ulcickas
    Wang, P. Feng
    Alford, S. Hensley
    Oliveria, S.
    Wells, K.
    Phillips, S.
    Ali, H.
    O'Malley, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck
    Lang, K.
    Sussman, M.
    Friedman, M.
    Su, J.
    Kan, H. J.
    Mauro, D.
    Menzin, J.
    VALUE IN HEALTH, 2008, 11 (03) : A67 - A67
  • [4] Incidence and Costs of Treatment-Related Complications Among Patients With Advanced Squamous Cell Carcinoma of the Head and Neck
    Lang, Kathleen
    Sussman, Matthew
    Friedman, Mark
    Su, Jun
    Kan, Hong J.
    Mauro, David
    Tafesse, Eskinder
    Menzin, Joseph
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (06) : 582 - 588
  • [5] Incidence of treatment-related toxicities in head and neck cancer Medicare patients
    McLaurin, KK
    Ciesla, G
    Kamimoto, PA
    Chico, I
    Apostolaros, M
    Leader, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 739S - 739S
  • [6] Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy
    Saba, Nabil F.
    Mody, Mayur D.
    Tan, Elaine S.
    Gill, Harpaul S.
    Rinaldo, Alessandra
    Takes, Robert P.
    Strojan, Primoz
    Hartl, Dana M.
    Vermorken, Jan B.
    Haigentz, Missak, Jr.
    Ferlito, Alfio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 115 : 50 - 58
  • [7] Future perspectives in the treatment of chemotherapy and radiotherapy for squamous cell carcinoma of the head and neck (SCCHN)
    Herchenhorn, D
    2ND WORLD CONGRESS OF THE INTERNATIONAL FEDERATION OF HEAD AND NECK ONCOLOGIC SOCIETIES, 2002, : 39 - 50
  • [8] Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung
    Brunner, Andrew M.
    Costa, Daniel B.
    Heist, Rebecca S.
    Garcia, Elizabeth
    Lindeman, Neal I.
    Sholl, Lynette M.
    Oxnard, Geoffrey R.
    Johnson, Bruce E.
    Hammerman, Peter S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (11) : 1434 - 1437
  • [9] REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN CANADA
    Byrne, K.
    Hallworth, P.
    Monafred, Tahami A. A.
    Moshyk, G.
    Shaw, J. W.
    VALUE IN HEALTH, 2017, 20 (05) : A138 - A139
  • [10] Estimated costs of treatment-related adverse events (TRAEs) for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the checkmate 141 trial
    Venkatachalam, M.
    Bobiak, S.
    Shaw, J. W.
    Santi, I.
    Contente, M.
    Korytowsky, B.
    Stenehjem, D. D.
    ANNALS OF ONCOLOGY, 2017, 28
12345